Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of Sodium Thiosulfate (STS) for Prevention of Ototoxicity in Patients With Locally Advanced Squamous Cell Carcinoma of Head and Neck (SCCHN) Undergoing Concurrent Chemoradiation With Cisplatin

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04541355
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:25.088718+00:00
Published At
2024-06-28T00:00:00+00:00
Record Updated At
2024-06-28
Results Posted At
2024-06-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Locally Advanced Head and Neck Squamous Cell Carcinoma", "Locally Advanced Hypopharyngeal Squamous Cell Carcinoma", "Locally Advanced Laryngeal Squamous Cell Carcinoma", "Locally Advanced Oral Cavity Squamous Cell Carcinoma", "Locally Advanced Oropharyngeal Squamous Cell Carcinoma", "Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Stage III Hypopharyngeal Carcinoma AJCC v8", "Stage III Laryngeal Cancer AJCC v8", "Stage III Lip and Oral Cavity Cancer AJCC v8", "Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IV Hypopharyngeal Carcinoma AJCC v8", "Stage IV Laryngeal Cancer AJCC v8", "Stage IV Lip and Oral Cavity Cancer AJCC v8", "Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVA Hypopharyngeal Carcinoma AJCC v8", "Stage IVA Laryngeal Cancer AJCC v8", "Stage IVA Lip and Oral Cavity Cancer AJCC v8", "Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVB Hypopharyngeal Carcinoma AJCC v8", "Stage IVB Laryngeal Cancer AJCC v8", "Stage IVB Lip and Oral Cavity Cancer AJCC v8", "Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVC Hypopharyngeal Carcinoma AJCC v8", "Stage IVC Laryngeal Cancer AJCC v8", "Stage IVC Lip and Oral Cavity Cancer AJCC v8", "Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-06-28"
protocolSection.identificationModule.nctId
"NCT04541355"
protocolSection.identificationModule.officialTitle
"A Phase II Study of Sodium Thiosulfate (STS) for Prevention of Ototoxicity in Patients With Locally Advanced Squamous Cell Carcinoma of Head and Neck (SCCHN) Undergoing Concurrent Chemoradiation With Cisplatin"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-06-28"

Study condition terms

  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Locally Advanced Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Hypopharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Laryngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Oral Cavity Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVC Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVC Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVC Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.